Di Sun

Title: Di Sun - Innovator in Thrombin-like Enzyme Research

Introduction

Di Sun is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biochemistry, particularly in the study of thrombin-like enzymes. His innovative work has led to the development of a unique enzyme isolated from snake venom, showcasing his expertise in protein research.

Latest Patents

Di Sun holds a patent for a thrombin-like enzyme that comprises an alpha subunit and a beta subunit linked by seven disulfide bonds. This enzyme, with a molecular weight of 29.3-29.5 kD and an isoelectric point of 5.5, is capable of hydrolyzing the alpha chain of human fibrinogen. The patent also details methods for purifying this enzyme from snake venom, which include several sophisticated techniques such as anion-exchange column chromatography and ultra-filtration.

Career Highlights

Throughout his career, Di Sun has worked with notable companies, including Konruns Pharmaceutical Co., Ltd. and The Fourth Paradigm (Beijing) Tech Co., Ltd. His experience in these organizations has allowed him to apply his research in practical settings, contributing to advancements in pharmaceutical applications.

Collaborations

Di Sun has collaborated with esteemed colleagues, including Xijuan Wang and Long Deng. These partnerships have further enriched his research and development efforts in the field of biochemistry.

Conclusion

Di Sun's innovative work in thrombin-like enzyme research exemplifies his dedication to advancing scientific knowledge. His contributions have the potential to impact various applications in medicine and biotechnology.